IL141050A0 - Muscarinic agonists and antagonists - Google Patents
Muscarinic agonists and antagonistsInfo
- Publication number
- IL141050A0 IL141050A0 IL14105099A IL14105099A IL141050A0 IL 141050 A0 IL141050 A0 IL 141050A0 IL 14105099 A IL14105099 A IL 14105099A IL 14105099 A IL14105099 A IL 14105099A IL 141050 A0 IL141050 A0 IL 141050A0
- Authority
- IL
- Israel
- Prior art keywords
- antagonists
- muscarinic agonists
- muscarinic
- agonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9697798P | 1998-08-18 | 1998-08-18 | |
PCT/US1999/018570 WO2000011001A1 (en) | 1998-08-18 | 1999-08-16 | Muscarinic agonists and antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
IL141050A0 true IL141050A0 (en) | 2002-02-10 |
Family
ID=22260061
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14105099A IL141050A0 (en) | 1998-08-18 | 1999-08-16 | Muscarinic agonists and antagonists |
Country Status (30)
Country | Link |
---|---|
US (5) | US6093724A (is) |
EP (1) | EP1112272B1 (is) |
JP (1) | JP2002523416A (is) |
KR (1) | KR20010072784A (is) |
CN (1) | CN1312812A (is) |
AR (1) | AR020199A1 (is) |
AT (1) | ATE227724T1 (is) |
AU (1) | AU750566B2 (is) |
BG (1) | BG105256A (is) |
BR (1) | BR9913072A (is) |
CA (1) | CA2340946A1 (is) |
CO (1) | CO5130018A1 (is) |
DE (1) | DE69903961T2 (is) |
EE (1) | EE200100096A (is) |
ES (1) | ES2191455T3 (is) |
HK (1) | HK1038918A1 (is) |
HU (1) | HUP0103203A3 (is) |
ID (1) | ID27544A (is) |
IL (1) | IL141050A0 (is) |
IS (1) | IS5827A (is) |
NO (1) | NO20010804L (is) |
NZ (1) | NZ509762A (is) |
PE (1) | PE20000988A1 (is) |
PL (1) | PL346247A1 (is) |
RU (1) | RU2219179C2 (is) |
SK (1) | SK1892001A3 (is) |
TR (1) | TR200100462T2 (is) |
WO (1) | WO2000011001A1 (is) |
YU (1) | YU13301A (is) |
ZA (1) | ZA200100978B (is) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SK4642003A3 (en) * | 2000-10-19 | 2004-05-04 | Pfizer Prod Inc | Bridged piperazine derivatives |
GB0117950D0 (en) * | 2001-02-16 | 2001-09-19 | Aventis Pharma Inc | Novel heterocyclic urea derivatives andd their use as dopamine D3 receptor ligands |
WO2002094827A1 (en) * | 2001-05-23 | 2002-11-28 | Neurosearch A/S | Fused tropane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
US20030064979A1 (en) * | 2001-06-29 | 2003-04-03 | Hansen Thomas Kruse | Method of inhibiting PTP 1B and /or T-cell PTP and/or other PTPases with an Asp residue at position 48 |
US6828328B1 (en) * | 2002-03-01 | 2004-12-07 | Ucb S.A. | Analgesic combination of muscarinic agonists |
US7897766B2 (en) * | 2005-09-23 | 2011-03-01 | Abbott Laboratories | Amino-aza-adamantane derivatives and methods of use |
US8314119B2 (en) * | 2006-11-06 | 2012-11-20 | Abbvie Inc. | Azaadamantane derivatives and methods of use |
US8076350B2 (en) | 2006-12-22 | 2011-12-13 | Abbott Laboratories | Spirocyclic azaadamantane derivatives and methods of use |
US8163914B2 (en) | 2007-03-23 | 2012-04-24 | Abbott Laboratories | Acetamide and carboxamide derivatives of azaadamantane and methods of use thereof |
EP2139891B1 (en) * | 2007-03-23 | 2012-09-05 | Abbott Laboratories | 4-substituted azaadamantane derivatives and methods of use thereof |
RU2549551C2 (ru) * | 2009-06-19 | 2015-04-27 | Эббви Инк. | Производные диазагомоадамантана и способы их применения |
US10265311B2 (en) | 2009-07-22 | 2019-04-23 | PureTech Health LLC | Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation |
US20110020423A1 (en) | 2009-07-22 | 2011-01-27 | Puretech Ventures | Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation |
AR081331A1 (es) | 2010-04-23 | 2012-08-08 | Cytokinetics Inc | Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos |
WO2011133920A1 (en) | 2010-04-23 | 2011-10-27 | Cytokinetics, Inc. | Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use |
AR081626A1 (es) | 2010-04-23 | 2012-10-10 | Cytokinetics Inc | Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos |
KR20130108586A (ko) | 2010-09-23 | 2013-10-04 | 애브비 인코포레이티드 | 아자아다만탄 유도체의 일수화물 |
US8759380B2 (en) | 2011-04-22 | 2014-06-24 | Cytokinetics, Inc. | Certain heterocycles, compositions thereof, and methods for their use |
EP3732163A4 (en) * | 2017-12-20 | 2021-07-14 | Vanderbilt University | MUSCARINIAN ACETYLCHOLINE RECEPTOR ANTAGONISTS M4 |
IL295341A (en) | 2018-09-28 | 2022-10-01 | Karuna Therapeutics Inc | Compositions and methods for the treatment of diseases improved by the activation of muscarinic receptors |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4739074A (en) * | 1986-01-22 | 1988-04-19 | Pennwalt Corporation | Adamantane spiro-pyrrolidine derivatives |
IE63906B1 (en) * | 1987-11-13 | 1995-06-14 | Novo Nordisk As | Azabicyclic compounds and their preparation and use |
US5527813A (en) * | 1990-08-21 | 1996-06-18 | Novo Nordisk A/S | Heterocyclic compounds and their preparation and use |
EP0563036A1 (en) * | 1990-12-21 | 1993-10-06 | Merck Sharp & Dohme Ltd. | 4-azatricyclo 2.2.1.0?2,6 ]heptanes and pharmaceutical compositions |
US5955470A (en) * | 1991-06-11 | 1999-09-21 | Merrell Pharmaceuticals, Inc. | Derivatives of amide analogs of certain methano bridged quinolizines |
US5641791A (en) * | 1991-08-13 | 1997-06-24 | Novo Nordisk A.S | Heterocyclic compounds and their preparation and use |
NZ321970A (en) * | 1995-11-02 | 2000-02-28 | Neurosearch As | Fused tropane-derivatives as neurotransmitter reuptake inhibitors |
US5914338A (en) * | 1996-04-02 | 1999-06-22 | Novo Nordisk | Heterocyclic compounds and their preparation and use |
US5986100A (en) * | 1998-04-02 | 1999-11-16 | Crooks; Peter Anthony | Pharmaceutical compositions and methods for use |
US6057446A (en) * | 1998-04-02 | 2000-05-02 | Crooks; Peter Anthony | Certain 1-aza-tricyclo [3.3.1-13,7 ] decane compounds |
US5952339A (en) * | 1998-04-02 | 1999-09-14 | Bencherif; Merouane | Pharmaceutical compositions and methods of using nicotinic antagonists for treating a condition or disorder characterized by alteration in normal neurotransmitter release |
-
1999
- 1999-08-16 US US09/375,149 patent/US6093724A/en not_active Expired - Fee Related
- 1999-08-16 RU RU2001107139/04A patent/RU2219179C2/ru not_active IP Right Cessation
- 1999-08-16 ES ES99945064T patent/ES2191455T3/es not_active Expired - Lifetime
- 1999-08-16 PL PL99346247A patent/PL346247A1/xx not_active Application Discontinuation
- 1999-08-16 WO PCT/US1999/018570 patent/WO2000011001A1/en not_active Application Discontinuation
- 1999-08-16 AU AU57758/99A patent/AU750566B2/en not_active Ceased
- 1999-08-16 BR BR9913072-6A patent/BR9913072A/pt not_active IP Right Cessation
- 1999-08-16 CA CA002340946A patent/CA2340946A1/en not_active Abandoned
- 1999-08-16 AT AT99945064T patent/ATE227724T1/de not_active IP Right Cessation
- 1999-08-16 EP EP99945064A patent/EP1112272B1/en not_active Expired - Lifetime
- 1999-08-16 KR KR1020017002128A patent/KR20010072784A/ko not_active Application Discontinuation
- 1999-08-16 CN CN99809775A patent/CN1312812A/zh active Pending
- 1999-08-16 ID IDW20010377A patent/ID27544A/id unknown
- 1999-08-16 DE DE69903961T patent/DE69903961T2/de not_active Expired - Fee Related
- 1999-08-16 JP JP2000566274A patent/JP2002523416A/ja active Pending
- 1999-08-16 NZ NZ509762A patent/NZ509762A/xx unknown
- 1999-08-16 IL IL14105099A patent/IL141050A0/xx unknown
- 1999-08-16 HU HU0103203A patent/HUP0103203A3/hu unknown
- 1999-08-16 EE EEP200100096A patent/EE200100096A/xx unknown
- 1999-08-16 YU YU13301A patent/YU13301A/sh unknown
- 1999-08-16 TR TR2001/00462T patent/TR200100462T2/xx unknown
- 1999-08-16 SK SK189-2001A patent/SK1892001A3/sk unknown
- 1999-08-17 AR ARP990104100A patent/AR020199A1/es unknown
- 1999-08-18 PE PE1999000838A patent/PE20000988A1/es not_active Application Discontinuation
- 1999-08-18 CO CO99052330A patent/CO5130018A1/es unknown
-
2000
- 2000-05-09 US US09/567,785 patent/US6251916B1/en not_active Expired - Fee Related
- 2000-10-17 US US09/690,494 patent/US6323194B1/en not_active Expired - Fee Related
-
2001
- 2001-01-26 IS IS5827A patent/IS5827A/is unknown
- 2001-02-05 ZA ZA200100978A patent/ZA200100978B/xx unknown
- 2001-02-14 BG BG105256A patent/BG105256A/xx unknown
- 2001-02-16 NO NO20010804A patent/NO20010804L/no not_active Application Discontinuation
- 2001-10-05 US US09/972,415 patent/US6423842B1/en not_active Expired - Fee Related
-
2002
- 2002-01-18 HK HK02100409.3A patent/HK1038918A1/zh unknown
- 2002-03-27 US US10/108,046 patent/US6555550B1/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1039963A1 (en) | Il-2 selective agonists and antagonists | |
PL331534A1 (en) | Muscarinic antagonists | |
IL141050A0 (en) | Muscarinic agonists and antagonists | |
SG85628A1 (en) | Compound and its use | |
HK1042084B (zh) | 取代的苯並咪唑及其製備和用途 | |
AU1772300A (en) | Glucagon antagonists/inverse agonists | |
IL128869A0 (en) | Pyrozolopyrimidines and pyrazolotriazines | |
GB9813271D0 (en) | Composition and use | |
IL140249A0 (en) | Muscarinic antagonists | |
SG80041A1 (en) | Muscarinic receptor antagonists | |
HUP0203896A3 (en) | Substituted 8-arylquinoline phosphodiesterase-4-inhibitors and use thereof | |
AUPP380498A0 (en) | Egf receptor agonists and antagonists | |
HUP0103473A3 (en) | Phosphoglycolipid and methods for its use | |
PL332616A1 (en) | Hydoxymethylhexanones as odorising and savourising agents | |
GB9803232D0 (en) | Compound composition and use | |
HK1043590A1 (zh) | 毒蕈碱性拮抗物 | |
AU5861900A (en) | Receptor agonists and antagonists | |
EP1242074A4 (en) | NMDA / NR2B ANTAGONISTS BASED ON 5-BENZYL-OCTAHYDROINDOLE AND 6-BENZYL-DECAHYDROQUINOLINE | |
HUP0004317A3 (en) | 5-ht1f agonists | |
AU9275001A (en) | Notch receptor agonists and uses | |
GB9820014D0 (en) | Receptor antagonists and uses thereof | |
GB9701374D0 (en) | Purinergic agonists and antagonists | |
IL137428A0 (en) | Estrogen agonists and antagonists for multiple indications | |
HU9902674D0 (en) | Estrogen agonists/antagonists | |
PL307138A1 (en) | Amyline antagonists and agonists |